PROGRESSION-free survivalREGRESSION analysisCOLORECTAL cancerCARCINOEMBRYONIC antigenObjective: Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) serve as pivotal tumor markers in colorectal cancer (CRC). However, uncertainty persists regarding the prognostic significance of the two tumor...
Modest DP, Schulz C, Boeck S. Prognostic value of CA 19–9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy. Journal of cancer research Clinical Oncology, 2013;158...
RETRACTED www.nature.com/scientificreports OPEN Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through received: 24 September 2015 upregulation of cavin-1 inaccepted:09December2015 Published:12January2016 patients with preoperative serum CA19-9 ≥ 1,000 U/mL Jin-Feng...
15 patients presented Lea or Leb above the cutoffs. By immunofluorescence, Lea, Leb and CA19.9 were all detected in cancer resections and expression levels were heterogeneous among patients in terms
As a promoter, CA19-9 could be used to evaluate the biology of pancreatic cancer. CA19-9 can accelerate pancreatic cancer progression by glycosylating proteins, binding to E-selectin, strengthening angiogenesis, and mediating the immunological response. CA19-9 is an attractive therapeutic target ...
ToinvestigatethepredictivevalueofCEAandCA19—9intumor progression,prognosisandneoadjuvantchemotherapyofadvancedgastriccancer.Methods Clinical dataof322patientswithadvancedgastriccancer(54casesundergoingneoadjuvantchemotherapy)from theAfiliatedOncologicHospitalofGuangzhouMedicalCollegewerereviewed.SerumCEAandCA19-9 ...
Background and Objectives CA19-9 is a cancer-associated carbohydrate antigen that plays a role in the process of tumor progression as an adhesion molecule. Methods We evaluated the prognostic value of CA19-9 tumor expression and CA19-9 preoperative and postoperative serum levels in colorectal canc...
Cancer-related venous thromboembolism (VTE) heralds a poor prognosis, especially in pancreatic adenocarcinoma (PAC). Tissue factor (TF) is implicated as one of the main culprits in PAC-associated VTE and disease progression. Methods: In a prospective cohort study of 79 PAC patients, we measured...
pancreatic cancersurvivalthrombosistissue factorBackground: Cancer-related venous thromboembolism (VTE) heralds a poor prognosis, especially in pancreatic adenocarcinoma (PAC). Tissue factor (TF) is implicated as one of the main culprits in PAC-associated VTE and disease progression.Methods: In a ...
2. M.M. Juretzka, R.R. Barakat, D.S. Chi, A. Iasonos, J. Dupont, N.R. Abu-Rustum, et al.,CA-125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consol...